Aurinia Pharmaceuticals Inc.

Kezar Life Sciences is a leading brand in the field of developing innovative therapies for chronic diseases. They specialize in creating small molecule therapies that target key intracellular proteins to inhibit disease-driving cellular pathways. The company's mission is to improve the lives of patients struggling with difficult-to-treat conditions by delivering unique treatments.

With a team of experts in target biology and medicinal chemistry, Kezar Life Sciences focuses on two main therapeutic approaches. The first is Selective Immunoproteasome Inhibition, which modulates the immune system to treat autoimmune diseases without direct immunosuppression. The second approach is Protein Secretion Inhibition, which halts the secretion of target proteins associated with cancers and autoimmune diseases.

Kezar Life Sciences is dedicated to discovering promising targets that were previously unidentified or undruggable, with the goal of revolutionizing the treatment paradigm for various conditions. Stay updated with their latest news and advancements on their website, and join them in their mission to provide groundbreaking therapies for chronic diseases